Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pleural effusions in the neonate

View through CrossRef
Abstract Introduction: Pleural effusions are rare in the neonate and may be associated to several clinical conditions. Only a few series of pleural effusions in the fetus and newborn are described in the literature. Aim: This study was undertaken to determine more accurately the causes and prognostic significance of pleural effusions in a population of high‐risk neonates. Materials and methods: A retrospective chart review of 62 neonates admitted to the neonatal intensive care unit of six medical centers in the north of Portugal, between 1997 and 2004, that presented the diagnosis of pleural effusion. Results: 33M/29F newborns; preterms 47 (76%); GA 33 (25–40) wk; BW 1830 (660–4270) g; C‐section 39 (63%). Pleural effusions were congenital in 20 (32%) newborns and acquired in 42 (68%). Congenital pleural effusions occurred as fetal hydrops in 11 (18%) patients and as chylothorax in 9 (15%). In four cases of hydrops, the cause was a congenital chylothorax. Congenital chylothorax (n=13) was the most common (65%) congenital pleural effusion in this study. The incidence of congenital chylothorax was 1:8.600 deliveries and male:female ratio was 2:1. Mortality occurred in five newborns due to pulmonary hypoplasia. Traumatic (iatrogenic) were the most frequent (n=31) acquired pleural effusions. These included 8 (13%) cases of hemothorax and 8 (13%) cases of total parenteral nutrition leakage. Pleural effusions after intra‐thoracic surgery were mainly (79%) chylothoraces. There were 11 (26%) non‐iatrogenic acquired pleural effusions. No mortality was associated with acquired pleural effusions. Conclusions: Congenital pleural effusions usually occur as hydrops or congenital chylothorax. Traumatic (iatrogenic) are the most frequent acquired pleural effusions in a tertiary NICU. Pleural effusions after intra‐thoracic surgery are mainly chylothoraces. Non‐iatrogenic acquired pleural effusions are associated to several clinical conditions, and mortality is usually associated to the underlying condition.
Title: Pleural effusions in the neonate
Description:
Abstract Introduction: Pleural effusions are rare in the neonate and may be associated to several clinical conditions.
Only a few series of pleural effusions in the fetus and newborn are described in the literature.
Aim: This study was undertaken to determine more accurately the causes and prognostic significance of pleural effusions in a population of high‐risk neonates.
Materials and methods: A retrospective chart review of 62 neonates admitted to the neonatal intensive care unit of six medical centers in the north of Portugal, between 1997 and 2004, that presented the diagnosis of pleural effusion.
Results: 33M/29F newborns; preterms 47 (76%); GA 33 (25–40) wk; BW 1830 (660–4270) g; C‐section 39 (63%).
Pleural effusions were congenital in 20 (32%) newborns and acquired in 42 (68%).
Congenital pleural effusions occurred as fetal hydrops in 11 (18%) patients and as chylothorax in 9 (15%).
In four cases of hydrops, the cause was a congenital chylothorax.
Congenital chylothorax (n=13) was the most common (65%) congenital pleural effusion in this study.
The incidence of congenital chylothorax was 1:8.
600 deliveries and male:female ratio was 2:1.
Mortality occurred in five newborns due to pulmonary hypoplasia.
Traumatic (iatrogenic) were the most frequent (n=31) acquired pleural effusions.
These included 8 (13%) cases of hemothorax and 8 (13%) cases of total parenteral nutrition leakage.
Pleural effusions after intra‐thoracic surgery were mainly (79%) chylothoraces.
There were 11 (26%) non‐iatrogenic acquired pleural effusions.
No mortality was associated with acquired pleural effusions.
Conclusions: Congenital pleural effusions usually occur as hydrops or congenital chylothorax.
Traumatic (iatrogenic) are the most frequent acquired pleural effusions in a tertiary NICU.
Pleural effusions after intra‐thoracic surgery are mainly chylothoraces.
Non‐iatrogenic acquired pleural effusions are associated to several clinical conditions, and mortality is usually associated to the underlying condition.

Related Results

Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
The Effectiveness of Pleural Cholesterol Levels in Differentiating Transudate from Exudate and Comparison with Light’s Criteria
The Effectiveness of Pleural Cholesterol Levels in Differentiating Transudate from Exudate and Comparison with Light’s Criteria
Background: Differentiating exudative from transudative pleural effusions is essential for accurate diagnosis and management. Although Light’s criteria remain the standard diagnost...
Role of pleural viscosity in the differential diagnosis of exudative pleural effusion
Role of pleural viscosity in the differential diagnosis of exudative pleural effusion
Objective and background:  Determining the aetiology of an effusion involves assessing if it is an exudate or a transudate. However, a reliable test for determining the aetiology o...
Transforming growth factor beta‐1 level in pleural effusion
Transforming growth factor beta‐1 level in pleural effusion
Objective:  Transforming growth factor‐β1 is an important immunomodulator. The diagnostic role of TGF‐β1 has not been systematically investigated in pleural effusion.Methodology:  ...
Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions
Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions
In this study we investigate the diagnostic value of pleural fluid procalcitonin (PCT) in distinguishing infectious and noninfectious etiologies of pleural effusion. We reviewed th...

Back to Top